Cosmax Nbt Future Growth
Future criteria checks 4/6
Cosmax Nbt wird ein jährliches Wachstum der Erträge und Einnahmen um 113.1% bzw. 8.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich grow um 110.8% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 25% betragen.
Key information
96.0%
Earnings growth rate
95.9%
EPS growth rate
Personal Products earnings growth | 31.3% |
Revenue growth rate | 8.8% |
Future return on equity | 25.1% |
Analyst coverage | Low |
Last updated | 15 Nov 2023 |
Recent future growth updates
Recent updates
Little Excitement Around Cosmax Nbt, Inc.'s (KOSDAQ:222040) Revenues As Shares Take 28% Pounding
Mar 19Here's Why Cosmax Nbt (KOSDAQ:222040) Is Weighed Down By Its Debt Load
Mar 11Cosmax Nbt (KOSDAQ:222040) Has Debt But No Earnings; Should You Worry?
Apr 06What Is The Ownership Structure Like For Cosmax Nbt, Inc. (KOSDAQ:222040)?
Mar 01Cosmax Nbt (KOSDAQ:222040) Share Prices Have Dropped 76% In The Last Five Years
Feb 02Should You Think About Buying Cosmax Nbt, Inc. (KOSDAQ:222040) Now?
Jan 04Is Cosmax Nbt (KOSDAQ:222040) Using Debt In A Risky Way?
Dec 09Is Cosmax Nbt, Inc.'s (KOSDAQ:222040) Shareholder Ownership Skewed Towards Insiders?
Nov 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 398,350 | 20,900 | N/A | 31,900 | 2 |
12/31/2024 | 373,600 | 15,400 | N/A | 26,200 | 2 |
12/31/2023 | 333,631 | -6,493 | -604 | 16,780 | N/A |
9/30/2023 | 326,835 | -16,522 | 3,019 | 21,425 | N/A |
6/30/2023 | 319,869 | -17,752 | 15,184 | 29,602 | N/A |
3/31/2023 | 330,026 | -15,653 | 13,137 | 22,018 | N/A |
12/31/2022 | 328,207 | -13,070 | 7,603 | 13,612 | N/A |
9/30/2022 | 326,015 | -2,285 | 11,853 | 16,855 | N/A |
6/30/2022 | 309,819 | -3,601 | 3,233 | 6,736 | N/A |
3/31/2022 | 298,331 | -5,800 | 4,546 | 8,358 | N/A |
12/31/2021 | 289,347 | -6,393 | -12,863 | -8,190 | N/A |
9/30/2021 | 274,288 | -10,784 | 852 | 6,952 | N/A |
6/30/2021 | 283,188 | -9,257 | 4,351 | 9,432 | N/A |
3/31/2021 | 275,415 | -7,972 | 3,666 | 10,613 | N/A |
12/31/2020 | 266,791 | -12,106 | 19,328 | 25,509 | N/A |
9/30/2020 | 255,972 | -17,637 | -3,856 | 1,268 | N/A |
6/30/2020 | 225,577 | -22,869 | -14,166 | -4,542 | N/A |
3/31/2020 | 202,281 | -23,653 | -19,941 | -9,292 | N/A |
12/31/2019 | 194,269 | -17,752 | -34,381 | -13,475 | N/A |
9/30/2019 | 209,704 | -3,181 | -46,600 | -9,769 | N/A |
6/30/2019 | 216,593 | 4,130 | -50,850 | -9,265 | N/A |
3/31/2019 | 212,015 | 6,085 | -51,296 | -8,233 | N/A |
12/31/2018 | 201,729 | 7,618 | -41,269 | -6,709 | N/A |
9/30/2018 | 179,466 | 5,416 | -29,703 | -8,452 | N/A |
6/30/2018 | 165,093 | 8,043 | -21,386 | -4,599 | N/A |
3/31/2018 | 151,518 | 7,971 | -17,683 | 4,686 | N/A |
12/31/2017 | 136,351 | 6,270 | -32,938 | 4,802 | N/A |
9/30/2017 | 124,023 | 10,062 | N/A | 15,667 | N/A |
6/30/2017 | 120,000 | 10,971 | N/A | 8,332 | N/A |
3/31/2017 | 121,090 | 14,574 | N/A | 8,052 | N/A |
12/31/2016 | 120,781 | 17,213 | N/A | 9,528 | N/A |
9/30/2016 | 115,911 | 14,309 | N/A | 1,288 | N/A |
6/30/2016 | 102,103 | 12,799 | N/A | 9,718 | N/A |
3/31/2016 | 88,737 | 10,623 | N/A | 5,810 | N/A |
12/31/2015 | 77,516 | 8,570 | N/A | 13,462 | N/A |
9/30/2015 | 69,264 | 7,242 | N/A | 15,449 | N/A |
6/30/2015 | 59,959 | 5,058 | N/A | 9,630 | N/A |
3/31/2015 | 51,746 | 3,202 | N/A | 8,832 | N/A |
12/31/2014 | 46,914 | 2,218 | N/A | 4,154 | N/A |
12/31/2013 | 39,207 | 2,060 | N/A | 3,029 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: A222040 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.4%).
Ertrag vs. Markt: A222040 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: A222040 wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: A222040Die Einnahmen des Unternehmens (8.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt KR (9.1% pro Jahr).
Hohe Wachstumseinnahmen: A222040Die Einnahmen des Unternehmens (8.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: A222040Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (25%)